{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1111.170",
  "meta" : {
    "versionId" : "10",
    "lastUpdated" : "2021-02-23T10:35:47.000-05:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "Lantana EH Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2023-02-28"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2021-02-23"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.170",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1111.170"
  }],
  "version" : "20210223",
  "name" : "DihydrocodeineScheduleIIAndIII",
  "title" : "Dihydrocodeine Schedule II and III",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-02-23T01:01:00-05:00",
  "publisher" : "Lantana EH Steward",
  "description" : "This value set includes semantic clinical drugs (SCD) and generic pack (GPCK) RxNorm codes.",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: The purpose of this value set is to group Schedules II and III Dihydrocodeine medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that identify medications of dihydrocodeine),(Exclusion Criteria: Excludes concepts that represent schedule I, V,  unscheduled, nonprescribable, non-human, and inactive Dihydrocodeine medications.)",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "concept" : [{
        "code" : "1234941",
        "display" : "chlorpheniramine maleate 0.4 MG/ML / dihydrocodeine bitartrate 0.6 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution"
      },
      {
        "code" : "1596108",
        "display" : "acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule"
      },
      {
        "code" : "1812164",
        "display" : "acetaminophen 325 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Tablet"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:83bad4c3-bdda-4634-acd1-bc236116933b",
    "timestamp" : "2023-09-26T10:06:26-04:00",
    "total" : 3,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1234941",
      "display" : "chlorpheniramine maleate 0.4 MG/ML / dihydrocodeine bitartrate 0.6 MG/ML / phenylephrine hydrochloride 1.5 MG/ML Oral Solution"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1596108",
      "display" : "acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1812164",
      "display" : "acetaminophen 325 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Tablet"
    }]
  }
}